Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Age range
18 Years – 80 Years
Last updated October 2021